GLP-1 Compounded Medications Targeted by Connecticut Attorney General On May 21, 2025, the Connecticut Office of the Attorney General released a statement and sent letters to Connecticut weight loss clinics, med spas, medical practices and other businesses regarding allegedly or potentially unfair and deceptive conduct relating to compounded GLP-1 medications
Is tirzepatide better than semaglutide when combined with metformin
A placebo-controlled trial of acetyl-L-carnitine and a-lipoic acid in the treatment of bipolar depression
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
to date, no studies have investigated the role of dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 RAs in SIH or SID
Next, she says that consuming it often at extremely high temperatures has been associated with increased reports of esophageal, lung, and bladder cancer